MRI characteristics due to gene mutations in a Chinese pedigree with Lafora disease

被引:2
|
作者
Sun, Yueqian [1 ]
Zhou, Ziqi [1 ]
Wang, Qun [1 ,2 ,3 ,4 ]
Yan, Jing [1 ,2 ]
Zhang, Zaiqiang [1 ,2 ]
Cui, Tao [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[2] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Inst Brain Disorders, Collaborat Innovat Ctr Brain Disorders, Beijing, Peoples R China
[4] Beijing Key Lab Neuromodulat, Beijing, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2023年 / 11卷 / 10期
关键词
brain atrophy; Lafora disease; MRI; mutation; pedigree; PROGRESSIVE MYOCLONUS EPILEPSY; GENOTYPE-PHENOTYPE CORRELATIONS; BODY DISEASE; STATUS EPILEPTICUS; EPM2A MUTATIONS; LATE-ONSET; PHOSPHATASE; DIAGNOSIS; SEIZURES; ATROPHY;
D O I
10.1002/mgg3.2228
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background and PurposeLafora disease (LD) is a very rare autosomal recessive disorder manifesting primarily as fatal, congenital, and neurodegenerative epilepsies. We aimed to describe the MRI characteristics due to gene mutations in a Chinese pedigree with LD. MethodsWhole-exome sequencing, muscle biopsy, pedigree analysis, and MRI analysis were conducted. Five family members (two of whom were affected by LD) were whole-genome sequenced. Longitudinal changes in brain MRI volumes were analyzed by Freesurfer. ResultsWe identified a new intron heterozygous mutation in the EMP2A gene c.71 (exon 1) G>A in a Chinese LD pedigree that was characterized by refractory seizures, progressive vision impairment, and declines in motor and cognitive functions. The patient suffered generalized tonic-clonic seizures since the age of 15 years and had severe forms of progressive myoclonic seizure. She eventually died after being admitted to the intensive care unit due to status epilepticus at the age of 24 years. Period acid Schiff staining showed positive polyglucosan particles in muscle biopsy specimens. Regions of atrophy in the whole brain, and especially in the hippocampus, were detected. ConclusionsWe identified a new heterozygous mutation (c.71+1G>A) in a Chinese LD pedigree, which broadens the mutation spectrum of LD genes. We found that the patient exhibited brain volumetric atrophy along with rapidly worsening symptoms. These results contribute to our understanding of LD.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Identification of a recombination event narrowing the Lafora disease gene region
    Maddox, LO
    Descartes, M
    Collins, J
    Keating, J
    Rosenfeld, S
    Palmer, C
    Carroll, AJ
    Kuzniecky, R
    JOURNAL OF MEDICAL GENETICS, 1997, 34 (07) : 590 - 591
  • [32] Two novel mutations in the α-galactosidase A gene in Chinese patients with Fabry disease
    Yang, CC
    Lai, LW
    Whitehair, O
    Hwu, WL
    Chiang, SC
    Lien, YHH
    CLINICAL GENETICS, 2003, 63 (03) : 205 - 209
  • [33] Analysis of gene mutations in Chinese patients with maple syrup urine disease
    Yang, Nan
    Han, Lianshu
    Gu, Xuefan
    Ye, Jun
    Qiu, Wenjuan
    Zhang, Huiwen
    Gong, Zhuwen
    Zhang, Yafen
    MOLECULAR GENETICS AND METABOLISM, 2012, 106 (04) : 412 - 418
  • [34] Novel Mutations of NODAL Gene in Chinese Patients with Congenital Heart Disease
    Sun, Lei
    Cheng, Longfei
    Dong, Hanquan
    Wang, Binbin
    Huang, Guoying
    Li, Zhongzhi
    Xie, Xiaodong
    Shen, Adong
    Li, Xiaotian
    Wang, Jing
    Li, Hui
    Ma, Xu
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (04) : 306 - 309
  • [35] Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson's disease
    Yu, Zhe
    Wang, Ting
    Xu, Jun
    Wang, Wei
    Wang, Guifang
    Chen, Chao
    Zheng, Lili
    Pan, Li
    Gong, Dianrong
    Li, Xueli
    Qu, Huaiqian
    Li, Fang
    Zhang, Bin
    Le, Weidong
    Han, Fabin
    JOURNAL OF HUMAN GENETICS, 2015, 60 (02) : 85 - 90
  • [36] Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson’s disease
    Zhe Yu
    Ting Wang
    Jun Xu
    Wei Wang
    Guifang Wang
    Chao Chen
    Lili Zheng
    Li Pan
    Dianrong Gong
    Xueli Li
    Huaiqian Qu
    Fang Li
    Bin Zhang
    Weidong Le
    Fabin Han
    Journal of Human Genetics, 2015, 60 : 85 - 90
  • [37] Malin restoration as proof of concept for gene therapy for Lafora disease
    Varea, Olga
    Guinovart, Joan J.
    Duran, Jordi
    BRAIN COMMUNICATIONS, 2022, 4 (04)
  • [38] Patient-Specific Mechanisms of Lafora Disease Mutations in the Human Glycogen Phosphatase
    Gentry, Matthew
    Brewer, M. Kathryn
    Raththagala, Madushi
    Wayne, Jeremiah
    Vander Kooi, Craig
    FASEB JOURNAL, 2018, 32 (01):
  • [39] Identification of biallelic intronic EPM2A mutations in a Lafora disease kindred
    Duan, Ruo-Nan
    Liu, Jin-De
    Zhao, Xiu-He
    Song, Cheng-Yuan
    JOURNAL OF HUMAN GENETICS, 2025, 70 (03) : 167 - 170
  • [40] Lafora disease in south India: Focus on specific phenotypic characteristics
    Satischandra, P.
    Sinha, S.
    Yasha, T. C.
    Shankar, S. K.
    Ganesh, S.
    EPILEPSIA, 2007, 48 : 70 - 70